Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells

Ähnliche Einträge

• Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
  von: Chen, W, et al.
  Veröffentlicht: (2018)
• Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
  von: Sandham, D, et al.
  Veröffentlicht: (2019)
• Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
  von: Hardman, C, et al.
  Veröffentlicht: (2019)
• Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
  von: Xue, L, et al.
  Veröffentlicht: (2019)
• Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma
  von: Veit J. Erpenbeck, et al.
  Veröffentlicht: (2016-12-01)